Brief: Mereo Biopharma Group Files Prospectus Relates To Sale Of Up To $28.3 Mln Or 17.9 Mln Adss By Aspire Capital Fund
18/02/2020 23:11
Feb 18 (Reuters) - Mereo BioPharma Group plc MPHM.L :
* MEREO BIOPHARMA GROUP PLC FILES PROSPECTUS RELATES TO SALE
OF UP
TO $28.3 MILLION OR 17.9 MILLION ADSS BY ASPIRE CAPITAL FUND,
LLC - SEC FILING
Source text: (https://bit.ly/2uNh7ic)
Further company coverage: MPHM.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand